​
​

Rockwell Medical (RMTI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Rockwell Medical Revenue Highlights

Latest Revenue (Y)

$83.61M

Latest Revenue (Q)

$25.83M

Main Segment (Y)

Concentrate Products

Main Geography (Y)

UNITED STATES

Rockwell Medical Revenue by Period

Rockwell Medical Revenue by Year

DateRevenueChange
2023-12-31-14.84%
2022-12-31-17.57%
2021-12-31--0.43%
2020-12-31-1.46%
2019-12-31--3.29%
2018-12-31-10.63%
2017-12-31-7.54%
2016-12-31--3.73%
2015-12-31-2.14%
2014-12-31-3.45%
2013-12-31-5.09%
2012-12-31-1.79%
2011-12-31--17.78%
2010-12-31-8.82%
2009-12-31-5.93%
2008-12-31-20.03%
2007-12-31-50.30%
2006-12-31-3.41%
2005-12-31-54.33%
2004-12-31-19.87%
2003-12-31-30.22%
2002-12-31-27.51%
2001-12-31-20.90%
2000-12-31-11.30%
1999-12-31-26.42%
1998-12-31-60.61%
1997-12-31--

Rockwell Medical generated $83.61M in revenue during NA 2023, up 14.84% compared to the previous quarter, and up 131.90% compared to the same period a year ago.

Rockwell Medical Revenue by Quarter

DateRevenueChange
2024-06-30-13.92%
2024-03-31-2.64%
2023-12-31--7.06%
2023-09-30-31.48%
2023-06-30--8.07%
2023-03-31-1.84%
2022-12-31-3.33%
2022-09-30-0.05%
2022-06-30-15.86%
2022-03-31-5.17%
2021-12-31--4.10%
2021-09-30-5.62%
2021-06-30--2.17%
2021-03-31-2.04%
2020-12-31--0.76%
2020-09-30--3.88%
2020-06-30-0.25%
2020-03-31-2.36%
2019-12-31-0.54%
2019-09-30-3.78%
2019-06-30--4.59%
2019-03-31--7.68%
2018-12-31-1.09%
2018-09-30-11.80%
2018-06-30--0.24%
2018-03-31-0.75%
2017-12-31-1.44%
2017-09-30-10.45%
2017-06-30--9.25%
2017-03-31-8.98%
2016-12-31-4.49%
2016-09-30--4.74%
2016-06-30--1.28%
2016-03-31--3.58%
2015-12-31--1.71%
2015-09-30-10.98%
2015-06-30--6.69%
2015-03-31--3.90%
2014-12-31-5.12%
2014-09-30-5.45%
2014-06-30-0.54%
2014-03-31--7.17%
2013-12-31-6.65%
2013-09-30-0.85%
2013-06-30-5.25%
2013-03-31--5.10%
2012-12-31-2.45%
2012-09-30-4.66%
2012-06-30-0.80%
2012-03-31-1.11%
2011-12-31--0.66%
2011-09-30-1.47%
2011-06-30--11.20%
2011-03-31--7.20%
2010-12-31--2.87%
2010-09-30--4.91%
2010-06-30-3.52%
2010-03-31-1.48%
2009-12-31-4.26%
2009-09-30-8.80%
2009-06-30-1.69%
2009-03-31--5.47%
2008-12-31-0.03%
2008-09-30-11.10%
2008-06-30--1.85%
2008-03-31-3.88%
2007-12-31--

Rockwell Medical generated $25.83M in revenue during Q2 2024, up 13.92% compared to the previous quarter, and up 131.34% compared to the same period a year ago.

Rockwell Medical Revenue Breakdown

Rockwell Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Drug Revenue-----
Concentrate Products-----
Upfront Fee-----
Product-----
License-----

Rockwell Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Concentrate Products (97.20%), and Drug Revenue (2.80%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Dec 18
Concentrate Products-----
Drug Revenue-----

Rockwell Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Concentrate Products (99.96%), and Drug Revenue (0.04%).

Rockwell Medical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES-----
Non-US-----

Rockwell Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (88.91%), and Non-US (11.09%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
UNITED STATES--------------------
Non-US--------------------
Non Us--------------------
U--------------------

Rockwell Medical's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (92.69%), and Non-US (7.31%).

Rockwell Medical Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PAHCPhibro Animal Health--
COLLCollegium Pharmaceutical--
ANIPANI Pharmaceuticals--
ITCIIntra-Cellular Therapies--
PROCProcaps Group--
EGRXEagle Pharmaceuticals--
KMDAKamada--
LFCRLifecore Biomedical--
ACORAcorda Therapeutics--
RMTIRockwell Medical--
AQSTAquestive Therapeutics--
CPIXCumberland Pharmaceuticals--
BFRIBiofrontera--
AGRXAgile Therapeutics--
GHSIGuardion Health Sciences--
SSICSilver Spike Investment--
EVOKEvoke Pharma--
ADMPAdamis Pharmaceuticals--
SXTCChina SXT Pharmaceuticals--
ACRXTalphera--
LSDILucy Scientific Discovery--
IXHLIncannex Healthcare--
HUGEFSD Pharma--
RGCRegencell Bioscience--

RMTI Revenue FAQ

What is Rockwell Medical’s yearly revenue?

Rockwell Medical's yearly revenue for 2023 was $83.61M, representing an increase of 14.84% compared to 2022. The company's yearly revenue for 2022 was $72.81M, representing an increase of 17.57% compared to 2021. RMTI's yearly revenue for 2021 was $61.93M, representing a decrease of -0.43% compared to 2020.

What is Rockwell Medical’s quarterly revenue?

Rockwell Medical's quarterly revenue for Q2 2024 was $25.83M, a 13.92% increase from the previous quarter (Q1 2024), and a 42.88% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $22.68M, a 2.64% increase from the previous quarter (Q4 2023), and a 15.29% increase year-over-year (Q1 2023). RMTI's quarterly revenue for Q4 2023 was $22.09M, a -7.06% decrease from the previous quarter (Q3 2023), and a 14.39% increase year-over-year (Q4 2022).

What is Rockwell Medical’s revenue growth rate?

Rockwell Medical's revenue growth rate for the last 3 years (2021-2023) was 35.01%, and for the last 5 years (2019-2023) was 36.39%.

What are Rockwell Medical’s revenue streams?

Rockwell Medical's revenue streams in c 23 are Drug Revenue, and Concentrate Products. Drug Revenue generated $2.34M in revenue, accounting 2.80% of the company's total revenue Concentrate Products generated $81.27M in revenue, accounting 97.20% of the company's total revenue

What is Rockwell Medical’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Rockwell Medical was Concentrate Products. This segment made a revenue of $81.27M, representing 97.20% of the company's total revenue.